TY  - JOUR
T1  - A Survey of Diagnosis and Treatment of Pet Canine Parvovirus Disease in China
AU - Tian, Ze-Hua AU - Zhao, Jin-Zi AU - Han, Shui-Zhong AU - Zhang, Xiao-Ying AU - Hu, Jian-Jun 
JO  - Journal of Animal and Veterinary Advances
VL  - 10
IS  - 16
SP  - 2058
EP  - 2060
PY  - 2011
DA  - 2001/08/19
SN  - 1680-5593
DO  - javaa.2011.2058.2060
UR  - https://makhillpublications.co/view-article.php?doi=javaa.2011.2058.2060
KW  - pet dog
KW  -Canine Parvovirus (CPV)
KW  -Monoclonal Antibody (McAb)
KW  -questionnaire survey
KW  -cost
KW  -China
AB  - The aim of the survey was to investigate epidemiology, diagnosis and therapy situations of pet Canine Parvovirus (CPV) disease in China and to provide data for further anti-CPV drug development. Questionnaire survey was carried out in 30 veterinary clinics in Beijing, Xi’an, Zhengzhou, Tianjin and Hanzhong in December, 2009. The proportions of CPV dogs in all clinic treated dogs were 15.64, 19.37 and 20.51% in 2007, 2008 and 2009, respectively with an increasing tendency. About 32.00% CPV positive dogs were vaccinated. Most of the unvaccinated dogs were puppies. Imported vaccine produces were used in 93.33% clinics and homegrown vaccines in 33.33% clinics (some clinics used both vaccines included). The CPV antigen test kits made in Korea were used in 96.67% clinics. As for the treatment, the average duration was 5.5 days and 90.00% clinics used CPV Monoclonal Antibody (McAb) while 42.70% of the total payment was expended in CPV McAb. The CPV McAbs were usually combined used with other drugs in treatment. Therefore, it was hard to evaluate the McAb drug effect. The McAb products are the main sources for CPV diagnosis and treatment. Information of CPV treatment is inadequate in China therefore, more surveys, technologies and produces should be developed in CPV diagnosis and therapy.
ER  -